BN Business News
添加企业 →
本文翻译正在准备中。在此之前,我们暂时显示英文原文。

商业 · 1995/8/291 分钟阅读

Drug Export; Atenolol Bulk Drug Substance

本地自动翻译 · 来源原始语言

摘要

The Food and Drug Administration (FDA) is announcing that IPR Pharmaceuticals, Inc., a part of Zeneca Group PLC, has filed an application requesting approval for the export of the bulk drug substance Atenolol to France to produce various approved finished formulations containing Atenolol alone or in combination.

来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →

探索专题

商业洞察 →